Skip to main content
SpringerLink
Log in

Anticoagulation in Atrial Fibrillation: Is Aspirin Sufficient?

  • Conference paper
Cardiac Arrhythmias 1995

  • 105 Accesses

Abstract

Atrial fibrillation (AF) carries a high risk of systemic embolism, in particular stroke. This is true not only when AF is associated with rheumatic valvular disease, but also in the so-called nonvalvular AF (NVAF) (1–7).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Halperin JL, Hart RG (1988) Atrial fibrillation and stroke: new ideas, persisting dilemmas (editorial). Stroke 19: 937–941

    Article  PubMed  CAS  Google Scholar 

  2. Cerebral Embolism Task Force (1989) Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol 46: 727–743

    Article  Google Scholar 

  3. Petersen P (1990) Thromboembolic complications in atrial fibrillation. Stroke 21: 4–13

    Article  PubMed  CAS  Google Scholar 

  4. Cairns JA, Connolly SJ (1991) Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy. Circulation 84: 469–481

    PubMed  CAS  Google Scholar 

  5. Hart RG (1992) Thromboembolism in nonrheumatic atrial fibrillation: what have we learned? In: Di Pasquale G, Pinelli G (eds) Heart-brain interactions. Springer, Berlin Heidelberg New York, pp 83–86

    Chapter  Google Scholar 

  6. The National Heart, Lung and Blood Institute Working Group on Atrial Fibrillation (1993) Atrial fibrillation: current understandings and research imperatives. J Am Coll Cardiol 32: 1830–1834

    Google Scholar 

  7. Hart RG, Halperin JL (1994) Atrial fibrillation and stroke: revisiting the dilemmas. Stroke 25: 1337–1341

    Article  PubMed  CAS  Google Scholar 

  8. Stein B, Fuster V, Halperin JL, Chesebro JH (1989) Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk. Circulation 80: 1501–1513

    Article  PubMed  CAS  Google Scholar 

  9. Chesebro JH, Fuster V, Halperin JL (1991) Atrial fibrillation: risk marker for stroke. N Engl J Med 323: 1556–1558

    Article  Google Scholar 

  10. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B (1989) Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1: 175–179

    Article  CAS  Google Scholar 

  11. The Stroke Prevention in Atrial Fibrillation Investigators (1991) The Stroke Prevention in Atrial Fibrillation trial: final results. Circulation 84: 527–539

    Google Scholar 

  12. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 325: 1505–1511

    Google Scholar 

  13. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C, for the CAFA study coinvestigators (1991) Canadian Atrial Fibrillation Anticoagulation ( CAFA) study. J Am Coll Cardiol 18: 349–355

    Article  PubMed  CAS  Google Scholar 

  14. Ezeckowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ, Rickles FR, Shabetai R, Deykin D, for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators (1992) Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 327: 1406–1412

    Google Scholar 

  15. The Stroke Prevention in Atrial Fibrillation Investigators (1992) Predictors of thromboembolism in atrial fibrillation: I. clinical features of patients at risk. Ann Intern Med 116: 1–5

    Google Scholar 

  16. Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 154: 1449–1457

    Article  Google Scholar 

  17. Di Pasquale G, Urbinati S, Ribani MA, Passarelli P, Pinelli G (1994) Clinical markers of embolic risk in patients with atrial fibrillation. G Ital Cardiol 24: 315–324

    PubMed  Google Scholar 

  18. Kopecky 51, Gersh BJ, Mc Goon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM, Frye RL (1987) The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 327: 1406–1412

    Google Scholar 

  19. The Stroke Prevention in Atrial Fibrillation Investigators (1992) Predictors of thromboembolism in atrial fibrillation: II. echocardiographic features of patients at risk. Ann Intern Med 116: 6–12

    Google Scholar 

  20. Di Pasquale G, Urbinati S, Pinelli G (1995) New echocardiographic markers of embolic risk in atrial fibrillation. Cerebrovasc Dis (in press)

    Google Scholar 

  21. Albers G, Atwood JE, Hirsch J, Sherman DG, Hughes RA, Connolly SJ (1991) Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med 115: 727–736

    PubMed  CAS  Google Scholar 

  22. Laupacis A, Albers G, Dunn M, Feinberg W (1992) Antithrombotic therapy in atrial fibrillation. Chest 102 [Suppl]: 426S - 433S

    Article  PubMed  CAS  Google Scholar 

  23. Stroke Prevention in Atrial Fibrillation Investigators (1994) Warfarin versus aspirin for prevention of thromboembolism in atrial fibrilllation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 346: 687–691

    Google Scholar 

  24. EAFT (European Atrial Fibrillation Trial) Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342: 1255–1262

    Google Scholar 

  25. Patrono C (1994) Aspirin as an antiplatelet drug. N Engl J Med 330: 1287–1294

    Article  PubMed  CAS  Google Scholar 

  26. Singer DE, Hughes RA, Gress DR, Sheehan MA, Oertel LB, Maraventano SW, Blewett DR, Rosner B, Kistler JP for the BAATAF Investigators (1992) The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: the BAATAF Study. Am Heart J 124: 1567–1573

    CAS  Google Scholar 

  27. Mc Anulty JH, Hart RG, Pearce RA for the SPAF Investigators (1993) Atrial fibrillation and thromboembolism: predictors of high risk during aspirin therapy. Circulation 88 [suppl]: 1–222 (abstr)

    Google Scholar 

  28. Bornstein NM, Karepov VG, Aronovich BD, Gorbulev AY, Treves TA, Korczyn AD (1994) Failure of aspirin treatment after stroke. Stroke 25: 275–277

    Article  PubMed  CAS  Google Scholar 

  29. Canadian Cooperative Study Group (1978) A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 299: 53–59

    Article  Google Scholar 

  30. UK-TIA Study Group (1988) United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. Br Med J 296: 316–320

    Article  Google Scholar 

  31. Antiplatelet Trialists’ Collaboration (1994) Collaborative overview of randomized trials of antiplatelet therapy–I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 306: 81–106

    Google Scholar 

  32. Flegel KM, Hanley J (1989) Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation. Stroke 20: 1000–1004

    Article  PubMed  CAS  Google Scholar 

  33. Moulton AW, Singer DE, Haas JS (1991) Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. Am J Med 91: 156–161

    Article  PubMed  CAS  Google Scholar 

  34. Corbalan R, Arriagada D, Braun S, Tapia J, Huete I, Kramer A, Chavez A (1992) Risk factors for systemic embolism in patients with paroxysmal atrial fibrillation. Am Heart J 124: 149–153

    Article  PubMed  CAS  Google Scholar 

  35. Di Pasquale G, Andreoli A, Lusa AM, Urbinati S, Grazi P, Carini GC, Ruffini M, Pinelli G (1990) Cerebral embolic risk in hypertrophie cardiomyopathy. In: Baroldi G, Camerini F, Goodwin JF (eds) Advances in cardiomyopathies. Springer, Berlin Heidelberg New York, pp 90–96

    Chapter  Google Scholar 

  36. Major Ongoing Stroke Trials (1995) Stroke 26: 349–353

    Google Scholar 

  37. Miller VT, Rothrock JF, Pearce LA, Feinberg WM, Hart RG, Anderson DC (1993) Ischemic stroke in patients with atrial fibrillation: clinical characteristics and the effect of aspirin. Neurology 43: 32–36

    PubMed  CAS  Google Scholar 

  38. Grotemeyer KH (1991) Effect of acetylsalicylic acid in stroke patients. Evidence of nonresponders in a subpopulation of treated patients. Thromb Res 63: 587–593

    Article  PubMed  CAS  Google Scholar 

  39. Fornaro GL, Rossi P, Mantica P, Caccia ME, Aralda D, Lavezzari M, Pamparana F, Milanesi G (1993) Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study. Circulation 87: 162–164

    PubMed  CAS  Google Scholar 

  40. Cataldo G, SIFA Study Group (1995) Secondary prevention of stroke in non-valvular atrial fibrillation: results of the SIFA (Studio Italiano Fibrillazione Atriale). J Am Coll Cardiol 25 [Suppl] 144A (abstr)

    Google Scholar 

  41. Gustafsson C, Blombäck M, Britton M, Hamsten A, Svensson J (1990) Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke 21: 47–51

    Article  PubMed  CAS  Google Scholar 

  42. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N (1990) Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 16: 377–380

    Article  PubMed  CAS  Google Scholar 

  43. Boysen G, Petersen P, Felding P (1991) Coagulation and fibrinolysis in patients with chronic atrial fibrillation. Cerebrovasc Dis 1: 235–238

    Article  Google Scholar 

  44. Yamamoto K, Ikeda V, Seino Y, Mito H, Fujikawa H, Sekiguchi H, Shimada K (1995) Coagulation activity is increased in the left atrium of patients with mitral stenosis. J Am Coll Cardiol 25: 1107–1112

    Google Scholar 

  45. Di Pasquale G, Ribani MA, Urbinati S, Passarelli P, Pinelli G (1995) Come si deve trattare oggi la fibrillazione atriale. In: Prati PL (ed) Conoscere e curare it cuore ‘85. CIBA Edizioni, Milan, pp 285–299

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione di Cardiologia, Ospedale Bellaria, Bologna, Italy

    G. Di Pasquale, S. Urbinati, M. A. Ribani, P. Passarelli, G. Labanti, M. L. Borgatti & G. Pinelli

Authors
  1. G. Di Pasquale
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Urbinati
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. A. Ribani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Passarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Labanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. L. Borgatti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Pinelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Divisione di Cardiologia, Ospedale Umberto I, Via Circonvallazione 50, I-30174, Venezia Mestre, Italy

    Antonio Raviele MD

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Italia, Milano

About this paper

Cite this paper

Di Pasquale, G. et al. (1996). Anticoagulation in Atrial Fibrillation: Is Aspirin Sufficient?. In: Raviele, A. (eds) Cardiac Arrhythmias 1995. Springer, Milano. https://doi.org/10.1007/978-88-470-2223-2_42

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2223-2_42

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-3-540-75012-3

  • Online ISBN: 978-88-470-2223-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation